West Pharmaceutical Services, Inc. (WST) Financials
Key financial figures for West Pharmaceutical Services, Inc. (Q2 2026).
- Revenue
- $872M
- Net Income
- $154M
- EPS
- $2.17
- Total Assets
- $4.1B
- Operating Cash Flow
- $124M
Full income statement, balance sheet, and cash flow for West Pharmaceutical Services, Inc. on SentiSense.